Clinical Trials Directory

Trials / Completed

CompletedNCT06348485

Massive Nasal Bleeding in Patients With NPC Received Curative RT

Massive Nasal Bleeding in Patients With Nasopharyngeal Carcinoma Received Curative Radiotherapy

Status
Completed
Phase
Study type
Observational
Enrollment
1,327 (actual)
Sponsor
Taichung Veterans General Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To investigate the incidence, predictive markers, and survival impact of massive nasal bleeding in nasopharyngeal carcinoma (NPC) patients who received curative radiotherapy (RT) with/without chemotherapy. A total of 1327 patients with previously untreated, biopsy-proven NPC, and no distant metastasis were retrospective reviewed. Investigators analyzed the occurrence rates of massive nasal bleeding between different characteristics and tried to identify important predictive factors. Investigators compared overall survival between patients with and without massive nasal bleeding by Kaplan-Meier method.

Conditions

Interventions

TypeNameDescription
OTHERPatients without massive nasal bleedingNo event of massive nasal bleeding after curative radiotherapy
OTHERPatients with massive nasal bleedingAny event of massive nasal bleeding after curative radiotherapy

Timeline

Start date
1994-12-01
Primary completion
2019-04-30
Completion
2024-02-29
First posted
2024-04-04
Last updated
2024-04-04

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT06348485. Inclusion in this directory is not an endorsement.